Baker Bros. Advisors LP 13D and 13G filings for Adaptimmune Therapeutics plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 4:21 pm Purchase |
2023-12-31 | 13G | Adaptimmune Therapeutics plc ADAP |
Baker Bros. Advisors LP | 65,815,692 4.800% |
6,830,430 (+11.58%) |
Filing |
| 2021-02-16 4:08 pm Purchase |
2020-12-31 | 13G | Adaptimmune Therapeutics plc ADAP |
Baker Bros. Advisors LP | 58,985,262 6.400% |
58,985,262 (New Position) |
Filing |